{
  "id": "58e79e703e8b6dc87c00000a",
  "type": "factoid",
  "question": "What percentage of rheumatoid arthritis patients are responsive to anti-TNF therapy?",
  "ideal_answer": "Despite this, a substantial proportion of patients (approximately 30-40%) fail to respond to these potentially toxic and expensive therapies. Treatment strategies blocking tumor necrosis factor (anti-TNF) have proven very successful in patients with rheumatoid arthritis (RA), showing beneficial effects in approximately 50-60% of the patients. ",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/22044414",
    "http://www.ncbi.nlm.nih.gov/pubmed/24040234"
  ],
  "snippets": [
    {
      "text": "Despite this, a substantial proportion of patients (approximately 30-40%) fail to respond to these potentially toxic and expensive therapies. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22044414",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Treatment strategies blocking tumor necrosis factor (anti-TNF) have proven very successful in patients with rheumatoid arthritis (RA), showing beneficial effects in approximately 50-60% of the patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24040234",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "50-60%"
}